Statistics for Leap Therapeutics (id:6957 LPTX)

Valuation metrics

Market cap

124.36M

Enterprise value

47.13M

Trailing P/E (ttm)

-0.67

Forward P/E

-2.60

PEG ratio

-2.60

Price/Sales (ttm)

Price/Book (mrq)

1.89

Enterprise Value/Revenue

Enterprise Value/EBITDA

-0.73

Overview

Shares outstanding

38.26M

Float

26.09M

Shares short

723.54K

% Held by insiders

0.17%

% Held by institutions

0.42%

Average volume (10 days)

342.11K

Average volume (90 days)

Price summary

52-Week low

1.68

52-Week high

5.00

52-Week change

-2.77%

Beta

0.22

50-Day moving average

2.93

200-Day moving average

2.67

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 21th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-45.62%

Return on equity

-80.54%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-64,688,000.00

Net income to common (ttm)

-60,343,000.00

Diluted EPS (ttm)

-0.98

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

78.48M

Total cash per share (mrq)

2.05

Total debt (mrq)

482.00K

Total Debt/Equity (mrq)

0.73

Current ratio (mrq)

510.20%

Book value per share (mrq)

1.72

Cash flow

Cash flow statement

-50,055,000.00

Levered free cash flow (LFCF)

-30,067,500.00